NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Wave Life Sciences Ltd (NASDAQ: WVE)

 
WVE Technical Analysis
5
As on 9th Dec 2025 WVE SHARE Price closed @ 21.31 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 8.94 & Strong Buy for SHORT-TERM with Stoploss of 12.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

WVESHARE Price

Open 19.90 Change Price %
High 21.73 1 Day 2.79 15.06
Low 17.90 1 Week 13.55 174.61
Close 21.31 1 Month 13.69 179.66
Volume 37853346 1 Year 6.21 41.13
52 Week High 21.31 | 52 Week Low 5.48
 
NASDAQ USA Most Active Stocks
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
NVDA 184.97 -0.31%
LMDX 0.02 0.00%
AKTS 0.04 0.00%
PLUG 2.21 2.31%
ONDS 9.23 2.33%
LILM 0.05 0.00%
PONO 1.72 2.38%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
LPTX 2.05 365.91%
OCG 10.27 291.98%
OCG 10.27 291.98%
NDRAW 0.03 200.00%
 
NASDAQ USA Top Losers Stocks
TBIO 0.00 -100.00%
FPAY 0.01 -94.74%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
OPI 0.06 -70.00%
OPI 0.06 -70.00%
 
 
WVE
Daily Charts
WVE
Intraday Charts
Whats New @
Bazaartrend
WVE
Free Analysis
 
WVE Important Levels Intraday
RESISTANCE28.69
RESISTANCE26.32
RESISTANCE24.86
RESISTANCE23.40
SUPPORT19.22
SUPPORT17.76
SUPPORT16.30
SUPPORT13.93
 
WVE Forecast December 2025
4th UP Forecast30.79
3rd UP Forecast27.75
2nd UP Forecast25.87
1st UP Forecast23.99
1st DOWN Forecast18.63
2nd DOWN Forecast16.75
3rd DOWN Forecast14.87
4th DOWN Forecast11.83
 
WVE Weekly Forecast
4th UP Forecast25.07
3rd UP Forecast23.86
2nd UP Forecast23.12
1st UP Forecast22.37
1st DOWN Forecast20.25
2nd DOWN Forecast19.50
3rd DOWN Forecast18.76
4th DOWN Forecast17.55
 
WVE Forecast2025
4th UP Forecast53.01
3rd UP Forecast42.84
2nd UP Forecast36.56
1st UP Forecast30.28
1st DOWN Forecast12.34
2nd DOWN Forecast6.06
3rd DOWN Forecast-0.22
4th DOWN Forecast-10.39
 
 
WVE Other Details
Segment EQ
Market Capital 227451392.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
WVE Address
WVE
 
WVE Latest News
 
Your Comments and Response on Wave Life Sciences Ltd
 
WVE Business Profile
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It develops WVE-120101 and WVE-120102, a stereopure therapeutic candidates, which are in Phase 1b/2a clinical trials for the treatment of Huntington's disease (HD); WVE-003, mutant huntingtin SNP3 program for the treatment of HD; WVE-004, C9orf72 program for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-N531, our Exon 53 program for the treatment of Duchenne muscular dystrophy; and ATXN3 program in SCA3. The company has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, and University of Massachusetts. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore. Address: Marina One East Tower, Singapore, Singapore, 018936
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service